Stay updated on IBI310 and Siltilimab in NPC Clinical Trial
Sign up to get notified when there's something new on the IBI310 and Siltilimab in NPC Clinical Trial page.

Latest updates to the IBI310 and Siltilimab in NPC Clinical Trial page
- ChecktodayChange DetectedRevision history updated: added v3.5.0 and removed v3.4.3.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3 in the page history.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedA new revision version v3.4.2 was added to the record history, replacing v3.4.1. This is a metadata update reflecting a page revision rather than changes to trial data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check44 days agoChange DetectedNew revision entry added: v3.4.1 replaces v3.4.0 in the Study Record Versions, a minor record-keeping update with no changes to the study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check65 days agoChange DetectedA new revision entry v3.3.4 was added to the record history, and the prior revision v3.3.3 was removed; these are administrative version-tracking changes with no impact on study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check87 days agoChange DetectedAdded Revision: v3.3.3 and removed HHS Vulnerability Disclosure and Revision: v3.3.2 from the page history.SummaryDifference0.2%

Stay in the know with updates to IBI310 and Siltilimab in NPC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IBI310 and Siltilimab in NPC Clinical Trial page.